Oncology is evolving rapidly. Targeted therapies, immunotherapies, and combination approaches are transforming treatment possibilities – but understanding what works in the real world is critical. High-quality real-world evidence bridges the gap between clinical trials and patient outcomes, enabling better clinical decisions, stronger market access strategies, and proven value across the healthcare ecosystem.
Adelphi Real World’s Disease Specific Programmes (DSPs) are designed to address these needs.
Our Oncology DSPs deliver robust, actionable real-world data and insights, tailored specifically for the complexities of all malignancies across disease stages:
Treatment Patterns
Benchmark real-world therapy choices across early-stage, advanced, and metastatic disease. Track treatment sequencing, combinations, and shifts across chemotherapy, targeted therapies, immunotherapy, and multimodal approaches, understanding what clinicians actually do versus what guidelines recommend.
Real-World Treatment Complexity
Capture the nuance that clinical guidelines often miss: how oncologists actually manage disease stage-by-stage, how they balance efficacy against tolerability, adapt to patient preferences, and respond to treatment resistance.
Patient Outcomes & Experience
Move beyond efficacy data. Track effectiveness, safety, tolerability, and quality of life as experienced by patients in everyday practice, identifying where treatments truly deliver value and where unmet needs persist.
Unmet Needs
Identify where current treatment approaches fall short, whether in efficacy, tolerability, disease management across stages, or patient experience. Reveal unaddressed clinical challenges and emerging patient needs that represent genuine opportunities for therapeutic innovation.
Oncology Disease Specific Programmes (DSP) Portfolio
Click on the hexagons to expand.
Why Choose Adelphi Real World for Your Oncology Research?
Global Reach
Our DSPs cover a broad range of countries, enabling cross-market comparisons and global insights into oncology practice patterns, treatment approaches, and healthcare systems management
Rigorous Methodology
We combine robust, real-world data collection with oncology expertise to ensure credible, clinically relevant evidence that informs strategic decision-making across all cancer types.
Strategic Insights
Whether informing clinical development, supporting market access, or engaging healthcare stakeholders, our Oncology DSPs deliver the evidence you need to make impactful decisions across the evolving oncology landscape
Current Countries Solid Tumours DSPs Cover
Who We Partner With
We collaborate with biopharmaceutical companies, oncology practices, healthcare providers, cancer centres, patient advocacy groups, and policymakers to generate insights that advance oncology research and improve outcomes for all patients with cancer
Ready to Learn More?
- Book a Meeting: Schedule a one-on-one introduction with our experts to explore how our real-world evidence solutions can support your oncology projects
- Request More Information: Interested in our global coverage, specific cancer type focus, or methodology? Contact us for tailored information and resources.
Discover how Adelphi Real World’s DSPs can help you navigate the evolving landscape of oncology. We look forward to partnering with you to drive better outcomes for patients worldwide.
Contact us today using the form below.
Conferences Attending
Observational Research